InfuSystem Holdings, Inc. (NYSEMKT:INFU) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

InfuSystem Holdings, Inc. (NYSEMKT:INFU) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item5.02.

Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

On June8, 2017, in connection with Mr.Steens termination, the
Company and Mr.Steen entered into a Separation Agreement and
General Release (the Separation Agreement). to the Separation
Agreement and in consideration of Mr.Steens general release and
his agreement to certain restrictive covenants, Mr.Steen will
receive certain severance benefits, including (a)any accrued but
unpaid bonus, if any, (b)a payment equal to 12 months of his
current base salary, payable over a period of 12 months, (c)any
target bonus to which he would otherwise be entitled if employed
during the next 12 months, if any, (d)for a period of three
months, an amount equal to the cost of his COBRA health benefits,
and (e)in lieu of receiving three months notice of termination, a
payment equal to three months of his current base salary, payable
over a period of three months.

The foregoing summary of the Separation Agreement does not
purport to be complete and is qualified in its entirety by
reference to the Separation Agreement, a copy of which is filed
as Exhibit 10.1 hereto and is incorporated by reference herein.

Item9.01 Financial Statements and Exhibits.

(d) Exhibits:

ExhibitNo.

Description

10.1 Separation Agreement and General Release, effective June8,
2017, by and between InfuSystem Holdings, Inc. and Eric
Steen.


About InfuSystem Holdings, Inc. (NYSEMKT:INFU)

InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.